or Try an Advanced Search...

    ETF Components for INCE - Franklin Income Equity Focus ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    JNJ C 0.01 3.16
    SO B 1.29 3.07
    XOM D 2.68 3.01
    VZ A 0.61 2.93
    CVX F 2.46 2.64
    ABBV B 1.51 2.38
    LMT A 0.86 2.36
    PG C 0.20 2.00

    Represented by ETF Holdings

    Keywords: S&P 500 Dow Jones Component Plastic Commodity Petrochemicals Crude Oil Gastrointestinal Infection Internet Access Natural Gas Petroleum Petroleum Products Skin Care Abu Dhabi National Oil Company Access Devices Adalimumab Advanced Prostate Cancer Aerospace Aircraft Alternative Fuel Anemia
    Industries: Drug Manufacturers - Major Oil & Gas Integrated Aerospace & Defense Household & Personal Products Telecom Services Utilities - Regulated Electric

    Recent News for Franklin Income Equity Focus ETF & its Holdings

    Date Stock Title
    Sep 28 JNJ Johnson & Johnson announces updated results from Phase 1b RedirecTT-1 study
    Sep 28 JNJ Johnson & Johnson provides updated results from Phase 1b TRIMM-2 study
    Sep 28 JNJ 2 Excellent Dividend Stocks to Buy With Less Than $200
    Sep 27 SO Hurricane Helene restoration progresses with 250,000+ customers restored; Georgia Power posts estimated restoration times for multiple communities
    Sep 27 LMT Lockheed Martin Missiles and Fire Control receives $3.23B contract
    Sep 27 JNJ J&J, Legend report Carvykti cut death risk by 45% in multiple myeloma study
    Sep 27 XOM 20 Geopolitical Events with Highest Impact on S&P 500
    Sep 27 JNJ J&J releases encouraging data on Talvey combination therapies
    Sep 27 JNJ Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma
    Sep 27 JNJ CARVYKTI® is the first and only cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line
    Sep 27 ABBV 15 Unhealthiest Countries in Latin America
    Sep 27 ABBV Bristol Cobenfy approval draws optimism from Street, though with caveats
    Sep 27 ABBV ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
    Sep 27 JNJ DARZALEX® (daratumumab)-based maintenance regimens show clinically meaningful deep and durable responses in transplant-eligible patients with newly diagnosed multiple myeloma
    Sep 27 JNJ DARZALEX FASPRO®-based quadruplet regimen significantly improves minimal residual disease negativity for newly diagnosed multiple myeloma patients for whom transplant is not planned
    Sep 27 ABBV AbbVie submits BLA for antibody-drug conjugate Teliso-V for NSCLC
    Sep 27 JNJ Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
    Sep 27 ABBV AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer
    Sep 27 SO 10,000+ advance personnel deployed by Georgia Power to restore power Friday morning following Hurricane Helene
    Sep 27 LMT Lockheed's Unit Secures a Contract for Czech Republic's F-35 Integration
    Under normal marketing conditions, the fund will invest at least 80% of its net assets in equity securities, and in derivatives and other instruments that have economic characteristics and provide investment exposure similar to equity securities.
    Exchange Traded Fund Structured Finance Wagering Management Cybernetics Structured Product
    Back to the Main INCE Page...